维普中文期刊产品整合服务
5篇 您的检索式:作者名="Winijkul"
    题名 作者 年代 出处 被引量
1Compositional characterization of PM 2.5 emitted from in-use diesel vehicles显示文摘Nguyen Thi Kim Oanh Worrarat Thiansathit Tami C. Bond R. Subramanian Ekbordin Winijkul Ittipol Paw-armart 2009Atmospheric Environment2009,,1:2
2Climate-relevant properties of diesel particulate emissions:results from a piggyback study in Bangkok,Thailand显示文摘SUBRAMANIAN R WINIJKUL E BOND T C 2009Environmental Science & Technology2009,43,11:1
3Comparison between the Efficacy of Switch Therapy and Conventional Therapy in PediatricCommunity- Acquired Pneumonia显示文摘In-iw S Winijkul G Sonjaipanich S 2015J Med Assoc Thai2015,98,9:1
4Global emission projections of particulate matter (PM): I. Exhaust emissions from on-road vehicles显示文摘Fang Yan Ekbordin Winijkul Soonkyu Jung Tami C. Bond David G. Streets 2011Atmospheric Environment2011,,28:1
5History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry显示文摘Objective To compare clinical outcomes between patients with and without history of major bleeding according to types of antithrombotic medications in patients with non-valvular atrial fibrillation(NVAF). Methods We conducted a multicenter registry of patients with NVAF during 2014 to 2017 in Thailand. The following data were collected: demographic data, type of NVAF, medical illness, components of CHA2DS2-VASc and HAS-BLED scores, history of bleeding and severity, investigations, and antithrombotic medications. Clinical outcomes were death, bleeding, and ischemic stroke/transient ischemic attack(TIA). Results There were a total of 3218 patients. The average age was 67.3 ± 11.3 years, and 58.3% were men. Sixty-nine patients(2.14%) had a history of major bleeding. Antithrombotic use was, as follows: 2126 patients(75.3%) received oral anticoagulant(OAC) alone, 555(17.2%) received antiplatelet alone, 298(9.3%) received both, and 239(7.4%) received neither. During follow-up, 9.9% had major adverse outcomes, including death(5.9%), ischemic stroke/TIA(2.5%), and major bleeding(4.0%). There were no significant differences in the types of antithrombotic medications between patients with and without history of major bleeding. Multivariate analysis revealed old age, low body mass index, hypertension, diabetes, heart failure, and history of major bleeding to be independently associated with major adverse outcome. Adverse events significantly increased in patients with OAC plus antiplatelet. Conclusions History of major bleeding was identified as a factor that significantly affects clinical outcome. Inappropriate use of OAC plus antiplatelet should be avoided. Special caution should be made in this high-risk patients.Rungroj Krittayaphong Arjbordin Winijkul Wattana Wongtheptien Chaiyasith Wongvipaporn Treechada Wisaratapong Rapeephon Kunjara-Na-Ayudhya Smonporn Boonyaratvej Pontawee Kaewcomdee Ahthit Yindeengam 2020Journal of Geriatric Cardiology2020,17,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费